Uterus Kontraktilitesini Azaltan İlaçlar

Özet

Referanslar

Hossain R, Paul M, Tolosa JM, et al. Preventing Preterm Birth: The Search for Tocolytic Synergism, Reproductive Sciences, 2025; 32:3262–3286.

Rosen H, Yogev Y. Assessment of uterine contractions in labor and delivery, American Journal of Obstetrics and Gynecology, 2023; Volume 228, Issue 5, Supplement, Pages S1209-S1221.

Jordan S. Pharmacology for Midwives (the evidence base for safe practice), Second Edition, Red Globe Press, 2010, ISBN: 978-0-230-21558-0.

Haas DM, Benjamin T, Sawyer R, et al. Short-term tocolytics for preterm delivery – current perspectives, International Journal of Women’s Health, 2014; 6 343–349.

Fan J, Lu Q, Chen J, et al. Comparative effectiveness and safety of nifedipine and magnesium sulfate as treatment options for preterm birth: a systematic review and meta-analysis, BMJ Open 2025;15: e085938.

Practice Bulletin No. 171: Management of Preterm Labor, Obstetrics & Gynecology, 2016; 128(4): p e155-e164, doi: 10.1097/AOG.0000000000001711.

Erol SA, Kırbaş A, Yengin YÜ. The Role Of Tocolytic Agents and Calcium Channel Blockers (Nifedipine) In Preterm Birth Management, The Journal of Gynecology - Obstetrics and Neonatology, 2020; Volume 17, Sayı 4, Sayfa: 621-628.

Lockwood CJ, Moore T, Copel J, Silver RM, Resnik R. Chapter: Cardiovascular Diseases, Creasy and Resnik's Maternal-Fetal Medicine Principles and Practice, Editors: Lorraine Dugoff, Judette Louis, 9th Edition, eBook ISBN: 9780323828505, 2022.

Agnew EJ, Ivy JR, Stock SJ, Chapman KE. Glucocorticoids, antenatal corticosteroid therapy and fetal heart maturation, J Mol Endocrinol. 2018 Jul;61(1): R61-R73. doi: 10.1530/JME-18-0077.

Crowther CA, Brown J, McKinlay CJ, Middleton P. Magnesium sulphate for preventing preterm birth in threatened preterm labor, Cochrane Database Syst Rev, 2014 (8).

Hall DG, McGaughey HS, Corey EL, Thornton WN. The effects of magnesium therapy on the duration of labor, Am J Obstet Gynecol, 1959; 78 (1), pp. 27-32.

Smith R. Parturition. N Engl J Med 2007 Jan 18;356(3):271–83.

van Winden T, Roos C, Mol BW, Pajkrt E, Oudijk MA. A historical narrative review through the field of tocolysis in threatened preterm birth, Eur J Obstet Gynecol Reprod Biol X., 2024 Apr 29:22:100313.

Farina MG, Billi S, Sordelli MS, Ribeiro ML, Di Girolamo G, Lombardi E, Franchi AM.Nitric oxide (NO) inhibits prostaglandin E2 9-ketoreductase (9-KPR) activity in human fetal membranes, Prostaglandins Other Lipid Mediat. 2006 May;79(3-4):260-70.

Smith GN, Walker MC, Ohlsson A, O’Brien K, Windrim R. Randomized double-blind placebo-controlled trial of transdermal nitroglycerin for preterm labor, Am J Obstet Gynecol: 2007 Jan:196 (1), pp. 37.e1-37.e8.

Sayfalar

69-82

Yayınlanan

19 Ocak 2026

Lisans

Lisans